Literature DB >> 12099307

Clinical utility and approaches for estimating insulin sensitivity in pregnancy.

Patrick M Catalano1, John P Kirwan.   

Abstract

Insulin sensitivity as estimated by using the hyperinsulinemic-euglycemic clamp during pregnancy has been related to maternal energy expenditure, fat accretion and fetal growth. To determine whether less time consuming and invasive methods could be employed, we examined whether selected indices of insulin sensitivity derived from an oral glucose tolerance test (IS(OGTT)) or fasting glucose/insulin levels (IS(QUICKI) and IS(HOMA)) can be used to predict insulin sensitivity in women before and during pregnancy. A 2-h euglycemic-hyperinsulinemic clamp (5 mol/L glucose, 40 mU x m(-2) x min (-1) insulin), and 120 min OGTT (75 g load pregravid, 100 g pregnant), was repeated on 15 women [10 with normal glucose tolerance (NGT) and 5 with gestational diabetes mellitus (GDM)], pregravid, and during both early (12-14 weeks) and late (34-36 weeks) pregnancy. An index of insulin sensitivity derived from the clamp (IS(CLAMP)) was obtained from glucose infusion rates adjusted for change in fat free mass and endogenous glucose production measured using [6,6(-2)H2]-glucose. Univariate analysis with combined groups and periods of pregnancy resulted in significant correlations between IS(CLAP) and IS(OGTT), (r2 = .74, P < .0001), IS(QUICKI) (r2 = .64, P < .0001), and IS(HOMA) (r2 = .53, P < .0001). The IS(OGTT) provided a significantly better correlation (P < .0001) than either IS(QUICKI') or IS(HOMA). Multivariate analysis revealed a significant group effect (P < .0003) on the prediction model, and separate equations were developed for the NGT (r2 = .64, P < .0001) and GDM (r2 = .85, P < .0001) groups. When subdivided by period of pregnancy the correlation between IS(CLAMP) and IS(OGTT) pregravid was r = .63, P = .0002, during early pregnancy; r2 = .80, P < .0001 and during late pregnancy; r2 = .64, P = .0002. The IS(OGTT) provides an excellent means of estimating maternal insulin sensitivity during pregnancy. The information obtained from the IS(OGTT) will be useful in making clinical decisions on maternal care and facilitating optimal pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099307     DOI: 10.1053/sper.2002.33977

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  10 in total

1.  Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

2.  Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes.

Authors:  W Todd Cade; Rachel A Tinius; Dominic N Reeds; Bruce W Patterson; Alison G Cahill
Journal:  Diabetes       Date:  2016-02-09       Impact factor: 9.461

3.  Association between sleep disordered breathing in early pregnancy and glucose metabolism.

Authors:  Laura Sanapo; Margaret H Bublitz; Alice Bai; Niharika Mehta; Geralyn M Messerlian; Patrick Catalano; Ghada Bourjeily
Journal:  Sleep       Date:  2022-04-11       Impact factor: 6.313

4.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

5.  Maternal serum adiponectin multimers in gestational diabetes.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

6.  Physical activity, sedentary behaviors, and estimated insulin sensitivity and secretion in pregnant and non-pregnant women.

Authors:  Anna Gradmark; Jeremy Pomeroy; Frida Renström; Susanne Steiginga; Margareta Persson; Antony Wright; Les Bluck; Magnus Domellöf; Steven E Kahn; Ingrid Mogren; Paul W Franks
Journal:  BMC Pregnancy Childbirth       Date:  2011-06-16       Impact factor: 3.007

7.  Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers.

Authors:  Vanessa I Ramirez; Evelyn Miller; Christiane L Meireles; Jonathan Gelfond; Debra A Krummel; Theresa L Powell
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-23

8.  Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy.

Authors:  H David McIntyre; Allan M Chang; Leonie K Callaway; David M Cowley; Alan R Dyer; Tatjana Radaelli; Kristen A Farrell; Larraine Huston-Presley; Saeid B Amini; John P Kirwan; Patrick M Catalano
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

9.  Maternal physical activity and insulin action in pregnancy and their relationships with infant body composition.

Authors:  Jeremy Pomeroy; Frida Renström; Anna M Gradmark; Ingrid Mogren; Margareta Persson; Les Bluck; Antony Wright; Steven E Kahn; Magnus Domellöf; Paul W Franks
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

10.  Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance.

Authors:  H Svensson; L Wetterling; M Bosaeus; B Odén; A Odén; E Jennische; S Edén; A Holmäng; M Lönn
Journal:  Int J Obes (Lond)       Date:  2015-11-13       Impact factor: 5.095

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.